R&D Targeting COVID-19 and cancer with immunotherapy advancement... Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.
News FDA grants three priority vouchers to psychedelics The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
